Status:
UNKNOWN
Intralesional Injection of Acyclovir Versus Candida Antigen in Treatment of Plantar Warts
Lead Sponsor:
Sohag University
Conditions:
Acyclovir and Candida Antigen in Treatment of Plantar Wart
Eligibility:
All Genders
18-50 years
Phase:
PHASE4
Brief Summary
This study aims to evaluate the efficacy of intralesional injection of acyclovir versus candida antigen in plantar wart patients will be randomly divided into 2 groups,At least 20 patients will be enr...
Detailed Description
patients will be randomly divided into 2 groups, group (1) and group (2). At least 20 patients will be enrolled in each group. Group 1: will be treated with intralesional injection of acyclovir (Acyc...
Eligibility Criteria
Inclusion
- The study will include patients with single or multiple planter wart. Age group 18:50 years old
Exclusion
- : patients with history of renal or liver disease, pregnant and lactating females, patients taking immunosuppressant drugs, patients who received any treatment for wart in the last month before the study.
Key Trial Info
Start Date :
June 13 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05429151
Start Date
June 13 2022
End Date
May 1 2023
Last Update
June 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag
Sohag, Egypt